C. Robert Horsburgh Jr, MD
Professor
Boston University School of Public Health
Global Health

MD, Case Western Reserve University
MS, Yale University
AB, Princeton University



Dr. Horsburgh has 30 years of experience in public health and medicine. He currently holds faculty positions in the Departments of Epidemiology, Biostatistics, Global Health and Medicine. Dr. Horsburgh teaches courses in the Epidemiology of AIDS, the Epidemiology of Tuberculosis and Vaccine Epidemiology. His research focuses on tuberculosis, nontuberculous mycobacterial infections and opportunistic infections in AIDS. Currently, he is involved in research in Brazil, India, South Africa, Tanzania, Vietnam and the Philippines. He is a member of the Board of Directors of the International Union Against Tuberculosis and Lung Disease (IUATLD) and Chairman of the Steering Committee of RESIST-TB, an international organization dedicated to improving MDR-TB treatment through Clinical Trials and dissemination of best practices (www.resisttb.org).

Professor
Boston University School of Public Health
Epidemiology


Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
Infectious Diseases

Professor
Boston University School of Public Health
Biostatistics


Boston Medical Center




DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial
08/21/2020 - 05/31/2025 (Multi-PI)
PI: C. Robert Horsburgh Jr, MD
The Regents of the University of California, San Francisco NIH NIAID
5U01AI152980-03

Optimal targeting for individual and population-level TB prevention
12/05/2019 - 11/30/2024 (Subcontract PI)
President and Fellows of Harvard College dba Harvard T.H. Chan School of Public Health NIH NIAID
5R01AI146555-05

RePORT India Phase II
11/20/2019 - 11/19/2024 (Subcontract PI)
CRDF Global USDA Agricult ResSvc


Tuberculosis Trial Consortium
10/01/2019 - 09/30/2024 (Subcontract PI)
Veterans Affairs Medical Center of Washington DC HHS CDC
20FED2000031PSE

Tuberculosis Trials Consortium
10/01/2014 - 09/30/2024 (Subcontract PI)
Veterans Affairs Medical Center of Washington DC HHS CDC


Prevention Policy Modeling Lab
09/30/2019 - 09/29/2024 (Subcontract PI)
Stanford University HHS CDC
5NU38PS004651

Transmission Of Tuberculosis Among illicit drug use Linkages (TOTAL)
08/01/2019 - 07/31/2024 (Subcontract PI)
Boston Medical Center Corporation NIH NIAID
5R01AI147316-05

Predictors of Resistance Emergence Evaluation in MDR-TB Patients on Treatment (PREEMPT)
08/15/2017 - 07/31/2024 (PI)
NIH/National Institute of Allergy & Infectious Diseases
5R01AI134430-05

Dartmouth-Boston University HIV-TB Research Training for the Infectious Disease Institute at Muhimbili University of Health and Allied Sciences
06/01/2018 - 06/30/2024 (Subcontract PI)
Dartmouth College NIH FIC
5D43TW009573-10

Providence/Boston Center for AIDS Research (CFAR): Core Support (Cores A, B, E, G, K, SWG)
07/01/2018 - 06/30/2023 (Subcontract PI)
The Miriam Hospital NIH NIAID
5P30AI042853-24

Showing 10 of 36 results. Show All Results

MDR-TB and HIV at RePORT Sites in India (Supplement)
08/24/2017 - 08/23/2018 (PI)
U.S. Civilian Research and Development Foundation National Science Fdn

Lifespan/Tufts/brown Center for AIDS Research (CFAR): Core K Clinical Sciences Core
07/01/2016 - 06/30/2018 (PI)
Miriam Hospital NIH-NIAID

BU Clinical HIV/AIDS Research Training Program
08/02/2010 - 07/31/2016 (PI)
NIH-NIAID
5T32AI052074-10

Boston Community Partnership Against HIV
09/30/2002 - 09/29/2005 (PI)
DHHS-Office Minority Hlth

History Of Hepatitis C Infecti
09/30/1999 - 06/30/2005 (PI)
NIH-NIDDK
5 R01 DK56410-05 & Supplement


Title


Yr Title Project-Sub Proj Pubs
2023 DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial 5U01AI152980-04
2022 DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial 5U01AI152980-03
2021 DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial 5U01AI152980-02
2021 Predictors of Resistance Emergence Evaluation in MDR-TB Patients on Treatment (PREEMPT) 5R01AI134430-05
2020 DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial 1U01AI152980-01
2020 Predictors of Resistance Emergence Evaluation in MDR-TB Patients on Treatment (PREEMPT) 5R01AI134430-04
2020 Clinical Core 5U19AI111276-08-7772 34
2019 Predictors of Resistance Emergence Evaluation in MDR-TB Patients on Treatment (PREEMPT) 5R01AI134430-03
2019 Clinical Core 5U19AI111276-07-7772 34
2018 Predictors of Resistance Emergence Evaluation in MDR-TB Patients on Treatment (PREEMPT) 5R01AI134430-02
Showing 10 of 56 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Rosen LV, Thielking AM, Dugdale CM, Montepiedra G, Kalk E, Kim S, LaCourse SM, Mathad JS, Freedberg KA, Horsburgh CR, Paltiel AD, Wood R, Ciaranello AL, Reddy KP. Tuberculosis Preventive Treatment for Pregnant People With Human Immunodeficiency Virus in South Africa: A Modeling Analysis of Clinical Benefits and Risks. Clin Infect Dis. 2024 Nov 15. PMID: 39544107
     
  2. Burman W, Horsburgh CR, Johnston J. Predictable excess hepatotoxicity in the SimpliciTB trial. Lancet Infect Dis. 2024 Oct 28. PMID: 39481423
     
  3. Prakash Babu S, Ezhumalai K, Raghupathy K, Karoly M, Chinnakali P, Gupte N, Paradkar M, Devarajan A, Dhanasekaran M, Thiruvengadam K, Dauphinais MR, Gupte AN, Shivakumar SB, Thangakunam B, Christopher DJ, Viswanathan V, Mave V, Gaikwad S, Kinikar A, Kornfeld H, Horsburgh CR, Chandrasekaran P, Hochberg NS, Salgame P, Gupta A, Roy G, Ellner J, Sinha P, Sarkar S. Factors Associated With Unfavorable Treatment Outcomes Among Persons With Pulmonary Tuberculosis: A Multicentric Prospective Cohort Study From India. Clin Infect Dis. 2024 Oct 15; 79(4):1034-1038.View Related Profiles. PMID: 38991034; PMCID: PMC11478802; DOI: 10.1093/cid/ciae367;
     
  4. Overbeck V, Malatesta S, Carney T, Myers B, Parry CDH, Horsburgh CR, Theron D, White LF, Warren RM, Jacobson KR, Bouton TC. Understanding the impact of pandemics on long-term medication adherence: directly observed therapy in a tuberculosis treatment cohort pre- and post-COVID-19 lockdowns. BMC Infect Dis. 2024 Oct 14; 24(1):1154.View Related Profiles. PMID: 39396938; PMCID: PMC11475609; DOI: 10.1186/s12879-024-09994-7;
     
  5. Hsieh YL, Horsburgh CR, Cohen T, Miller JW, Salomon JA, Menzies NA. Cost-effectiveness of screening with transcriptional signatures for incipient TB among U.S. migrants. medRxiv. 2024 Oct 09. PMID: 39417109; PMCID: PMC11483025; DOI: 10.1101/2024.10.09.24315062;
     
  6. Swartwood NA, Li Y, Regan M, Marks SM, Barham T, Beeler Asay GR, Cohen T, Hill AN, Horsburgh CR, Khan AD, McCree DH, Myles RL, Salomon JA, Self JL, Menzies NA. Estimated Health and Economic Outcomes of Racial and Ethnic Tuberculosis Disparities in US-Born Persons. JAMA Netw Open. 2024 Sep 03; 7(9):e2431988. PMID: 39254977; PMCID: PMC11388029; DOI: 10.1001/jamanetworkopen.2024.31988;
     
  7. Campbell JI, Lavache D, Garing A, Sabharwal V, Haberer JE, Dubois M, Jenkins HE, Brooks MB, Joseph NT, Kissler K, Horsburgh CR, Jacobson KR. Evaluation of the Tuberculosis Infection Care Cascade Among Pregnant Individuals in a Low-Tuberculosis-Burden Setting. Open Forum Infect Dis. 2024 Sep; 11(9):ofae494.View Related Profiles. PMID: 39238842; PMCID: PMC11376066; DOI: 10.1093/ofid/ofae494;
     
  8. Wijk M, Gausi K, Malatesta S, Weber SE, Court R, Myers B, Carney T, Parry CDH, Horsburgh CR, White LF, Wiesner L, Warren RM, Uren C, McIlleron H, Kloprogge F, Denti P, Jacobson KR. The impact of alcohol and illicit substance use on the pharmacokinetics of first-line TB drugs. J Antimicrob Chemother. 2024 Aug 01; 79(8):2022-2030.View Related Profiles. PMID: 38985541; PMCID: PMC11290884; DOI: 10.1093/jac/dkae206;
     
  9. Cirillo D, Anthony R, Gagneux S, Horsburgh CR, Hasan R, Darboe S, Laniado-Laborin R, Probandari A, Tukvadze N, Arcêncio RA, Bimba JS, Brighenti S, Chesov D, Chiang CY, Kalmambetova G, Knight G, Konstantynovska O, Kruse A, Lange C, Mayanja-Kizza H, McBryde E, Min J, Sanchez-Montalva A, Sulis G, Tsogt B, Van Der Walt M, Yeboah-Manu D, Hauser J. A successful UN High-Level Meeting on antimicrobial resistance must build on the 2023 UN High-Level Meeting on tuberculosis. Lancet Glob Health. 2024 Aug; 12(8):e1225-e1226. PMID: 39030054
     
  10. Menzies NA, Swartwood NA, Cohen T, Marks SM, Maloney SA, Chappelle C, Miller JW, Beeler Asay GR, Date AA, Horsburgh CR, Salomon JA. The long-term effects of domestic and international tuberculosis service improvements on tuberculosis trends within the USA: a mathematical modelling study. Lancet Public Health. 2024 Aug; 9(8):e573-e582. PMID: 39095134; PMCID: PMC11344642; DOI: 10.1016/S2468-2667(24)00150-6;
     
Showing 10 of 369 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 352 publications over 43 distinct years, with a maximum of 23 publications in 2024

YearPublications
19811
19833
19844
19855
19865
19875
19884
198914
19904
19916
19928
19939
19947
19958
19965
19978
19985
19997
20008
20012
20025
20034
20045
20053
20069
20073
20087
20093
201011
201114
20128
201310
20149
201512
201611
20179
201819
201915
202021
202118
20224
202311
202423


Bump or spike? COVID in wastewater has experts unsurprised but wary

WBUR 12/6/2022

What to know about COVID's upswing in Massachusetts

WBUR 5/13/2022

Experts predict a COVID ‘swell’ — rather than a ‘wave’ — as cases tick upward in Mass.

WBUR 4/14/2022

What health experts expect from the next COVID phase in Massachusetts

WBUR 2/18/2022

With pediatric COVID vaccines a reality, experts reexamine whether ‘herd immunity’ is possible

WBUR 11/4/2021

Tuberculosis, Like Covid, Spreads by Breathing, Scientists Report

The New York Times 10/19/2021

COVID-19 hospitalizations have dropped over the week in Maine

WABI 10/8/2021

Baystate Business: Gaming, Dining, Covid (Radio)

Bloomberg 8/9/2021

Rate of breakthrough cases in Cape Cod cluster raises questions at CDC

The Boston Globe 7/30/2021

Provincetown COVID-19 cases climb to 882

The Boston Globe 7/29/2021

Provincetown leaders impose stricter mask rules amid COVID-19 case surge

The Boston Globe 7/25/2021

Brookline, Salem cautious as they continue local COVID-19 outdoor mask mandates (

The Boston Globe 5/3/2021

Brookline, Salem cautious as they continue local COVID-19 outdoor mask mandates

The Boston Globe 5/2/2021

Biden, public health officials face crossroads on COVID-19

The Boston Globe 3/14/2021

Texas Restaurants, Bars to Reopen at Full Capacity; Workers Not Yet Eligible for Vaccine

Food & Wine 3/3/2021

Live Blog: American life begins to return to normal, even as some fear it’s too soon.

The New York Times 3/2/2021

Texas Drops Its Virus Restrictions as a Wave of Reopenings Takes Hold

The New York Times 3/2/2021

Stadium supper, dance zones, rethinking oysters: News from around our 50 states

USA Today 3/2/2021

Moving forward in Massachusetts reopening 'careless, reckless,' Somerville mayor says

WCVB 3/1/2021

Baker pledges continued focus on vaccine equity, stands by moving forward with Mass. reopening

The Boston Globe 3/1/2021

Baker stands by loosening reopening restrictions, expects Johnson & Johnson vaccine supply later this month

The Boston Globe 3/1/2021

Baystate Business: Re-Opening Controversy (Radio)

Bloomberg 3/1/2021

‘Charlie, you’re making a big mistake’: Experts criticize state’s Monday reopening

The Boston Globe 2/28/2021

Baystate Business: Legends of Local TV (Radio)

Bloomberg 12/3/2020

COVID-19 impact from Thanksgiving travel and gatherings could be ‘precursor’ for upcoming holidays

The Boston Globe 11/29/2020

Troubling signs emerge that COVID-19 is tightening its hold on the state

The Boston Globe 11/1/2020

State reports more than 1,100 new coronavirus cases, prompting calls for a new state plan

The Boston Globe 10/24/2020

Baystate Business: Covid on the Rise (Radio)

Bloomberg 10/5/2020

Testing, schools, and a vaccine: What these experts are watching this fall amid COVID-19 in Mass

The Boston Globe 8/16/2020

Boston, Phase 3 reopening is all about safety, business owners say

The Boston Globe 7/12/2020

Scientists warn May 18 ‘still feels too early’ to begin reopening Mass.

The Boston Globe 5/12/2020

4 Bright Spots Amid the Gloom of Coronavirus

The New York Times 3/27/2020

Mass. Needs More Coronavirus Testing Now, Public Health Experts Say

WBUR 3/17/2020

Mass. increases coronavirus testing, ‘but it’s not nearly enough,’ some say

The Boston Globe 3/15/2020

2015 International Union Against Tuberculosis and Lung Disease, North American Region: Lifetime Achievement Award
2011 Boston University School of Public Health: Faculty Career Award in Research and Scholarship
2011 CDC: Excellence in Public Health Impact Award
2004 BUSPH: Teaching Award
1997 Emory University: Teaching Award
1989 US PHS Commendation Medal
1977 Lubrizol Award for Patient Care
Contact for Mentoring:

801 Massachusetts Avenue
Boston MA 02118
Google Map


Horsburgh's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department